Leeza Osipenko
Impact in
-
- Chronic Lymphocytic Leukemia Research
- Hemoglobinopathies and Related Disorders
- Economics and Econometrics top 10%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 11
- Pharmaceutical Economics and Policy 9
- Innovation Policy and R&D 3
- Economic and Financial Impacts of Cancer 2
-
- Biotechnology and Related Fields 2
- Co-authors
- Alexander Poletaev (1 shared paper)Elías Mossialos (7 shared papers)Huseyin Naci (5 shared papers)Jack W. Scannell (1 shared paper)Deborah Morrison (1 shared paper)John A. Hickman (1 shared paper)Michael Anderson (1 shared paper)Rob Anderson (1 shared paper)
- Journals
- Health Technology Assessment (2 papers)BMJ Open (2 papers)International Journal of Technology Assessment in Health Care (2 papers)Value in Health (2 papers)JAMA Network Open (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Leeza Osipenko
20 papers receiving 307 citations
Peers
Comparison fields: 5 of 89
- Genetics 46
- Economics and Econometrics 115
- Hematology 46
- Statistics and Probability 21
- Immunology 42
Countries citing papers authored by Leeza Osipenko
This map shows the geographic impact of Leeza Osipenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leeza Osipenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leeza Osipenko more than expected).
Fields of papers citing papers by Leeza Osipenko
This network shows the impact of papers produced by Leeza Osipenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leeza Osipenko. The network helps show where Leeza Osipenko may publish in the future.
Co-authors
The 25 scholars most cited alongside Leeza Osipenko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 64 | |
| 2 | 2016 | 53 | |
| 3 | 2012 | 44 | |
| 4 | 2012 | 34 | |
| 5 | 2018 | 30 | |
| 6 | 2023 | 22 | |
| 7 | 2022 | 11 | |
| 8 | 2018 | 10 | |
| 9 | 2020 | 9 | |
| 10 | 2021 | 7 | |
| 11 | 2016 | 6 | |
| 12 | 2020 | 6 | |
| 13 | 2014 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2019 | 4 | |
| 16 | System dynamics in early health technology assessment (ehta): prenatal screening technology (eli-p complex) | 2005 | 3 |
| 17 | 2017 | 2 | |
| 18 | 2018 | 1 | |
| 19 | Flow diagram of included studies | 2012 | 1 |
| 20 | National telemedicine and telehealth policy context in England and introduction of digital innovations for detection and treatment of sexually transmitted infections | 2017 | 1 |
About Leeza Osipenko
Leeza Osipenko is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health, Physiology, Molecular Biology and Genetics, having authored 22 papers that have together received 317 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (11 papers), Pharmaceutical Economics and Policy (9 papers), Innovation Policy and R&D (3 papers), Biomedical Ethics and Regulation (3 papers), Economic and Financial Impacts of Cancer (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Pharmaceutical industry and healthcare (2 papers) and Biotechnology and Related Fields (2 papers). The work is most often cited by research in Genetics (46 citations), Economics and Econometrics (115 citations), Hematology (46 citations), Statistics and Probability (21 citations) and Immunology (42 citations). Leeza Osipenko has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Alexander Poletaev, Elías Mossialos, Huseyin Naci, Jack W. Scannell, Deborah Morrison, John A. Hickman, Michael Anderson, Rob Anderson, Mary Gemma Cherry and Ruth Garside. Their work appears in journals such as Health Technology Assessment, BMJ Open, International Journal of Technology Assessment in Health Care, Value in Health and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.